Diagnósticos da América Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Simply Wall St · 09/28 11:03

Diagnósticos da América (BVMF:DASA3) Second Quarter 2024 Results

Key Financial Results

  • Revenue: R$3.96b (up 8.9% from 2Q 2023).
  • Net loss: R$104.1m (loss narrowed by 63% from 2Q 2023).
  • R$0.14 loss per share (improved from R$0.38 loss in 2Q 2023).
earnings-and-revenue-growth
BOVESPA:DASA3 Earnings and Revenue Growth September 28th 2024

All figures shown in the chart above are for the trailing 12 month (TTM) period

Diagnósticos da América Revenues Beat Expectations, EPS Falls Short

Revenue exceeded analyst estimates by 3.3%. Earnings per share (EPS) missed analyst estimates.

Looking ahead, revenue is forecast to grow 6.4% p.a. on average during the next 3 years, compared to a 9.4% growth forecast for the Healthcare industry in Brazil.

Performance of the Brazilian Healthcare industry.

The company's shares are down 1.1% from a week ago.

Risk Analysis

We should say that we've discovered 1 warning sign for Diagnósticos da América that you should be aware of before investing here.